Human Proto-Oncogene c-Ret ELISA Kit from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
Human Proto-Oncogene c-Ret ELISA Kit

Get Pricing

Description

This Human Proto-Oncogene c-Ret ELISA Kit is intended for quantitative detection of human RET in cell culture supernates, serum and plasma (heparin). Strip well format. Reagents for up to 96 tests.
This human RET ELISA Kit was based on standard sandwich enzyme-linked immune-sorbent assay technology. A monoclonal antibody from mouse specific for RET has been precoated onto 96-well plates. Standards (Expression system for standard: sf21, Immunogen sequence: L29-R635) and test samples are added to the wells, a biotinylated detection polyclonal antibody from goat specific for RET is added subsequently and then followed by washing with PBS or TBS buffer. Avidin-Biotin-Peroxidase Complex was added and unbound conjugates were washed away with PBS or TBS buffer. HRP substrate TMB was used to visualize HRP enzymatic reaction. TMB was catalyzed by HRP to produce a blue color product that changed into yellow after adding acidic stop solution. The density of yellow is proportional to the human Fibronectin amount of sample captured in plate.
The capture antibody is a monoclonal antibody from mouse, the detection antibody is a biotinylated detection polyclonal antibody from goat. Expression system for standard: This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. It is mapped to 10q11.21. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis